» Articles » PMID: 9062365

Relationship Between Interleukin-5 and Eotaxin in Regulating Blood and Tissue Eosinophilia in Mice

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1997 Mar 1
PMID 9062365
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism of cooperation between IL-5 and eotaxin for the selective accumulation of eosinophils at sites of allergic inflammation is unknown. In this investigation we have used IL-5 deficient mice to define the relationship between this cytokine and eotaxin in the regulation of blood eosinophilia and eosinophil homing and tissue accumulation. Both IL-5 and eotaxin could independently induce a rapid and pronounced blood eosinophilia in wild type mice when administered systemically. In contrast, only eotaxin induced a pronounced blood eosinophilia in IL-5 deficient mice. The eosinophilic response induced by intravenous eotaxin in wild type mice did not correlate with a significant reduction in the level of bone marrow eosinophils, whereas intravenous IL-5 resulted in depletion of this store. These results suggest the existence of two mechanisms by which eosinophils can be rapidly mobilized in response to intravenous eosinophil chemoattractants; first, mobilization of an IL-5 dependent bone marrow pool, and second, an eotaxin-induced sequestration of eosinophils from tissues into the blood. Subcutaneous injection of eotaxin induced a local tissue eosinophilia in wild type mice but not in IL-5 deficient mice. Furthermore, tissue eosinophilia in wild type mice, but not in IL-5 deficient mice, was enhanced by adoptive transfer of eosinophils or the administration of intravenous IL-5. However, pretreatment of IL-5 deficient mice with intraperitoneal IL-5 for 72 h restored eosinophil homing and tissue accumulation in response to subcutaneous eotaxin. We propose that eotaxin secreted from inflamed tissue may play an important role in initiating both blood and tissue eosinophilia in the early phases of allergic inflammation. Furthermore, IL-5 is not only essential for mobilizing eosinophils from the bone marrow during allergic inflammation, but also plays a critical role in regulating eosinophil homing and migration into tissues in response to eotaxin and possibly other specific chemotactic stimuli.

Citing Articles

Eosinophils: old cells, new directions.

Sanchez Santos A, Socorro Avila I, Galvan Fernandez H, Cazorla Rivero S, Lemes Castellano A, Cabrera Lopez C Front Med (Lausanne). 2025; 11:1470381.

PMID: 39886455 PMC: 11780905. DOI: 10.3389/fmed.2024.1470381.


Dietary and water restriction leads to increased susceptibility to antimicrobial resistant pathogens.

Lacey K, Pickrum A, Gonzalez S, Bartnicki E, Castellaw A, Rodrick T Sci Adv. 2024; 10(30):eadi7438.

PMID: 39047095 PMC: 11268424. DOI: 10.1126/sciadv.adi7438.


Nutrient-derived signals regulate eosinophil adaptation to the small intestine.

Kutyavin V, Korn L, Medzhitov R Proc Natl Acad Sci U S A. 2024; 121(5):e2316446121.

PMID: 38271336 PMC: 10835075. DOI: 10.1073/pnas.2316446121.


CD1a promotes systemic manifestations of skin inflammation.

Hardman C, Chen Y, Wegrecki M, Ng S, Murren R, Mangat D Nat Commun. 2022; 13(1):7535.

PMID: 36477177 PMC: 9729296. DOI: 10.1038/s41467-022-35071-1.


Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.

Guo Y, Mei Z, Li D, Banerjee A, Khalil M, Burke A Am J Transplant. 2022; 22(8):1963-1975.

PMID: 35510760 PMC: 9357103. DOI: 10.1111/ajt.17084.


References
1.
Foster P, Hogan S, Ramsay A, Matthaei K, Young I . Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996; 183(1):195-201. PMC: 2192412. DOI: 10.1084/jem.183.1.195. View

2.
Collins P, Marleau S, Jose P, Williams T . Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995; 182(4):1169-74. PMC: 2192289. DOI: 10.1084/jem.182.4.1169. View

3.
Kopf M, Brombacher F, Hodgkin P, Ramsay A, Milbourne E, Dai W . IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 1996; 4(1):15-24. DOI: 10.1016/s1074-7613(00)80294-0. View

4.
Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany H . Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem. 1996; 271(13):7725-30. DOI: 10.1074/jbc.271.13.7725. View

5.
Rothenberg M, Ownbey R, Mehlhop P, Loiselle P, van de Rijn M, Bonventre J . Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med. 1996; 2(3):334-48. PMC: 2230145. View